“…A prospective study reported an adolescent developing cardiomyopathy while on eteplirsen, consistent with DMD's typical progression [ 27 ]. It has also been shown that DMD is associated with an increased likelihood of cardiac events [ 28 ]and can precipitate respiratory failure [ 29 ]. Whether the causative factors behind these complications are inherent to the disease itself or are triggered or exacerbated by the medication deserves further investigation We call for vigilance in these adverse effects of concern so that appropriate preventive measures can be taken.…”